Autosomal Dominant Hypocalcemia Type 1: A Systematic Review-Reference-Cited by-同舟云学术

Autosomal Dominant Hypocalcemia Type 1: A Systematic Review

Published:2022-08-22 Issue:10 Volume:37 Page:1926-1935
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Roszko Kelly L¹^ORCID,Stapleton Smith Lyndsay M²,Sridhar Ananth V²,Roberts Mary Scott²,Hartley Iris R¹^ORCID,Gafni Rachel I¹^ORCID,Collins Michael T¹^ORCID,Fox Jonathan C²,Nemeth Edward F³^ORCID

Affiliation:

1. Skeletal Disorders & Mineral Homeostasis Section NIDCR, NIH Bethesda MD USA

2. Calcilytix Therapeutics, Inc. San Francisco CA USA

3. MetisMedica Toronto Canada

Funder

National Institute of Dental and Craniofacial Research

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4659

Reference49 articles.

1. Autosomal dominant hypoparathyroidism: a proband with concurrent nephrogenic diabetes insipidus.

2. Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation

3. A Familial Syndrome of Hypocalcemia with Hypercalciuria Due to Mutations in the Calcium-Sensing Receptor

4. Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism

5. Activating Mutations of the Calcium-Sensing Receptor: Management of Hypocalcemia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary hypoparathyroidism associated with catatonia in a patient with bipolar affective disorder: A case report;Psychiatry Research Case Reports;2024-06

2. New insights into renal calcium-sensing receptor activation;Current Opinion in Nephrology & Hypertension;2024-05-01

3. Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia;European Journal of Endocrinology;2024-03-30

4. G protein-coupled receptor (GPCR) gene variants and human genetic disease;Critical Reviews in Clinical Laboratory Sciences;2024-03-18

5. In vivo treatment with calcilytic of CaSR knock‐in mice ameliorates renal phenotype reversing downregulation of the vasopressin‐AQP2 pathway;The Journal of Physiology;2024-02-17